Federal Policymakers Should Urgently and Greatly Expand Naloxone Access.

An editorial is presented in which the authors argue in favor of U.S. government policies that would rapidly expand access to the narcotic overdose reversal medication naloxone. The article references the 2021 Model Expanded Access to Emergency Opioid Antagonists Act, conversion to an intranasal over-the-counter (OTC) version of naloxone, and the expansion of community-based efforts to reduce opioid overdoses.